Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) Images
Generic Name: sodium oxybate
This medication has been identified as Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate). It is supplied by Jazz Pharmaceuticals plc.
Xyrem is used in the treatment of Idiopathic Hypersomnia; Narcolepsy; Cataplexy and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. There is no proven risk in humans during pregnancy. Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Xyrem
- Generic Name
- sodium oxybate
- Strength
- 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate)
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Jazz Pharmaceuticals plc
- National Drug Code (NDC)
- 68727-0100
More about Xyrem (sodium oxybate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (109)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
